These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30569287)

  • 1. Hinokitiol Offers Neuroprotection Against 6-OHDA-Induced Toxicity in SH-SY5Y Neuroblastoma Cells by Downregulating mRNA Expression of MAO/α-Synuclein/LRRK2/PARK7/PINK1/PTEN Genes.
    Varier KM; Sumathi T
    Neurotox Res; 2019 May; 35(4):945-954. PubMed ID: 30569287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthraquinone from Edible Fungi Pleurotus ostreatus Protects Human SH-SY5Y Neuroblastoma Cells Against 6-Hydroxydopamine-Induced Cell Death-Preclinical Validation of Gene Knockout Possibilities of PARK7, PINK1, and SNCA1 Using CRISPR SpCas9.
    J B; Das A; Sakthivel KM
    Appl Biochem Biotechnol; 2020 Jun; 191(2):555-566. PubMed ID: 31820379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycyrrhizic Acid Alleviates 6-Hydroxydopamine and Corticosterone-Induced Neurotoxicity in SH-SY5Y Cells Through Modulating Autophagy.
    Yang G; Li J; Cai Y; Yang Z; Li R; Fu W
    Neurochem Res; 2018 Oct; 43(10):1914-1926. PubMed ID: 30206804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maackiain Ameliorates 6-Hydroxydopamine and
    Tsai RT; Tsai CW; Liu SP; Gao JX; Kuo YH; Chao PM; Hung HS; Shyu WC; Lin SZ; Fu RH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway.
    Ge H; Yan Z; Zhu H; Zhao H
    Exp Mol Pathol; 2019 Aug; 109():16-24. PubMed ID: 31067440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hesperidin downregulates kinases lrrk2 and gsk3β in a 6-OHDA induced Parkinson's disease model.
    Kesh S; Kannan RR; Sivaji K; Balakrishnan A
    Neurosci Lett; 2021 Jan; 740():135426. PubMed ID: 33075420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway.
    Urano Y; Mori C; Fuji A; Konno K; Yamamoto T; Yashirogi S; Ando M; Saito Y; Noguchi N
    Autophagy; 2018; 14(11):1943-1958. PubMed ID: 30112966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
    Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
    J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70.
    Batelli S; Albani D; Rametta R; Polito L; Prato F; Pesaresi M; Negro A; Forloni G
    PLoS One; 2008 Apr; 3(4):e1884. PubMed ID: 18382667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein.
    Ho DH; Seol W; Son I
    Cell Cycle; 2019 Feb; 18(4):467-475. PubMed ID: 30712480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson's Disease Through Upregulating Nrf2.
    Jing X; Wei X; Ren M; Wang L; Zhang X; Lou H
    Neurochem Res; 2016 Apr; 41(4):779-86. PubMed ID: 26537816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia.
    Kim T; Vemuganti R
    J Cereb Blood Flow Metab; 2017 Jun; 37(6):1910-1926. PubMed ID: 28273718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson's Disease.
    Anantha J; Goulding SR; Tuboly E; O'Mahony AG; Moloney GM; Lomansey G; McCarthy CM; Collins LM; Sullivan AM; O'Keeffe GW
    Mol Neurobiol; 2022 Jan; 59(1):61-76. PubMed ID: 34623600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
    Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
    Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DJ-1-Mediated protective effect of protocatechuic aldehyde against oxidative stress in SH-SY5Y cells.
    Gao JW; Yamane T; Maita H; Ishikawa S; Iguchi-Ariga SM; Pu XP; Ariga H
    J Pharmacol Sci; 2011; 115(1):36-44. PubMed ID: 21160133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
    Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
    Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
    Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease model organism for Parkinson disease: Drosophila melanogaster.
    Aryal B; Lee Y
    BMB Rep; 2019 Apr; 52(4):250-258. PubMed ID: 30545438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.